tiprankstipranks
Advertisement
Advertisement

NIOX Launches 2026 Employee Share Save Scheme With Discounted Options

Story Highlights
  • NIOX launched a three-year 2026 Save As You Earn Scheme granting discounted share options to UK staff.
  • The scheme covers 99,042 options, including 40,426 for the CEO, signalling incentive alignment with shareholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
NIOX Launches 2026 Employee Share Save Scheme With Discounted Options

Claim 55% Off TipRanks

Circassia Pharmaceuticals ( (GB:NIOX) ) has provided an announcement.

NIOX Group plc has launched its 2026 Save As You Earn Scheme for eligible UK employees, granting options over ordinary shares at a 20% discounted exercise price of 45.02 pence. The three-year savings plan is intended to broaden employee share ownership and align staff interests more closely with the company’s long-term performance.

In total, 99,042 options have been granted, representing about 0.02% of NIOX’s issued share capital, with 40,426 options awarded to Chief Executive Officer Jonathan Emms as a person discharging managerial responsibilities. The modest scale of the scheme limits dilution for existing shareholders while signalling continued use of equity-based incentives to retain key talent and support corporate growth objectives.

The most recent analyst rating on (GB:NIOX) stock is a Buy with a £86.00 price target. To see the full list of analyst forecasts on Circassia Pharmaceuticals stock, see the GB:NIOX Stock Forecast page.

Spark’s Take on NIOX Stock

According to Spark, TipRanks’ AI Analyst, NIOX is a Neutral.

The score is primarily supported by strong financial quality (growth, profitability, low debt, and solid cash generation). It is held back by bearish technical signals (price below major moving averages and negative MACD) and a high P/E that is only partly offset by the dividend yield.

To see Spark’s full report on NIOX stock, click here.

More about Circassia Pharmaceuticals

NIOX Group plc, listed on AIM, operates in the healthcare sector and focuses on respiratory diagnostics through its NIOX-branded products. The company targets clinicians and healthcare systems seeking non-invasive tools to support the management of conditions such as asthma and other airway inflammations.

Average Trading Volume: 755,109

Technical Sentiment Signal: Buy

Current Market Cap: £281.9M

For detailed information about NIOX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1